Evaluation and management considerations for neonates at risk for COVID-19

Updated Oct. 23, 2020This guidance is intended to inform healthcare providers in the United States about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates ( 6428 days old) with suspected or confirmed SARS-CoV-2 infection or known SARS-CoV-2 exposure, including birth to a mother with suspected or confirmed COVID-19.Summary of Recent ChangesUpdates as of August 3, 2020\u2022 Updated guidance on mother-neonate contact, emphasizing the importance of maternal autonomy in the medical decision-making process.\u2022 Updated evidence about routes of SARS-CoV-2 transmission to neonates.Routes of transmission -- Clinical presentation and disease severity -- Testing recommendations -- Infection prevention and control -- Mother/neonatal contact -- Disposition -- References.2020E:\cpapFiles\WebServer\COVIDneonates2020oct23.pdfhttps://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html855